Gene expression changes presage neurodegeneration in a Drosophila model of Parkinson's disease

Human Molecular Genetics

Volumn 12, Issue 19, 2003, Pages 2457-2466

  Scherzer, Clemens R ^a   Jensen, Roderick V ^a,b   Gullans, Stevens R ^a   Feany, Mel B ^c  

^a Brigham and Women's Hospital Center for Neurologic Diseases   (United States)

^b WESLEYAN UNIVERSITY   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN; LIPID; MESSENGER RNA; NEUROPROTECTIVE AGENT; TAU PROTEIN;

AGE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE SEVERITY; DOPAMINERGIC NERVE CELL; DROSOPHILA; DRUG SCREENING; ENERGY TRANSFER; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENETIC ASSOCIATION; GENETIC CODE; GENETIC TRANSCRIPTION; LEWY BODY; LIPID TRANSPORT; LOCOMOTION; NERVE DEGENERATION; NEUROPROTECTION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RNA TRANSPORT; TRANSGENIC ANIMAL;

ALPHA-SYNUCLEIN; ANIMALS; ANIMALS, GENETICALLY MODIFIED; DISEASE MODELS, ANIMAL; DROSOPHILA; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENOME; HUMANS; LEWY BODIES; MUTATION; NERVE DEGENERATION; NERVE TISSUE PROTEINS; PARKINSON DISEASE; POLYMERASE CHAIN REACTION; SYNUCLEINS; TAU PROTEINS; TIME FACTORS; TRANSCRIPTION, GENETIC; TRANSGENES;

ANIMALIA; EUKARYOTA;

EID: 0141841634     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: 10.1093/hmg/ddg265     Document Type: Article

References (42)

1. Fearnley, J.M. and Lees, A.J. (1991) Ageing and Parkinson's disease: substantia nigra regional selectivity. Brain, 114, 2283-2301.
2. Feany, M.B. and Bender, W.W. (2000) A Drosophila model of Parkinson's disease. Nature, 404, 394-398.
3. Puthalakath, H. and Strasser, A. (2002) Keeping killers on a tight leash: transcriptional and post-translational control of the pro-apoptotic activity of BH3-only proteins. Cell Death Differ., 9, 505-512.
4. Owuor, E.D. and Kong, A.N. (2002) Antioxidants and oxidants regulated signal transduction pathways. Biochem. Pharmac., 64, 765-770.
5. Tusher, V.G., Tibshirani, R. and Chu, G. (2001) Significance analysis of microarrays applied to the ionizing radiation response. Proc. Natl Acad. Sci. USA, 98, 5116-5121.
6. Adams, M.D., Celniker, S.E., Holt, R.A., Evans, C.A., Gocayne, J.D., Amanatides, P.G., Scherer, S.E., Li, P.W., Hoskins, R.A., Galle, R.F. et al. (2000) The genome sequence of Drosophila melanogaster. Science, 287, 2185-2195.
7. Lotharius, J. and Brundin, P. (2002) Pathogenesis of Parkinson's disease: dopamine, vesicles and alpha-synuclein. Nat. Rev. Neurosci., 3, 932-942.
8. Hsu, L.J., Sagara, Y., Arroyo, A., Rockenstein, E., Sisk, A., Mallory, M., Wong, J., Takenouchi, T., Hashimoto, M. and Masliah, E. (2000) Alpha-synuclein promotes mitochondrial deficit and oxidative stress. Am. J. Pathol., 157, 401-410.
9. Clayton, D.F. and George, J.M. (1999) Synucleins in synaptic plasticity and neurodegenerative disorders. J. Neurosci. Res., 58, 120-129.
10. Conway, K.A., Rochet, J.C., Bieganski, R.M. and Lansbury, P.T., Jr (2001) Kinetic stabilization of the alpha-synuclein protofibril by a dopamine-alpha-synuclein adduct. Science, 294, 1346-1349.
11. Xu, J., Kao, S.Y., Lee, F.J., Song, W., Jin, L.W. and Yankner, B.A. (2002) Dopamine-dependent neurotoxicity of alpha-synuclein: a mechanism for selective neurodegeneration in Parkinson disease. Nat. Med., 8, 600-606.
12. Blau, N., Bonafe, L. and Thony, B. (2001) Tetrahydrobiopterin deficiencies without hyperphenylalaninemia: diagnosis and genetics of dopa-responsive dystonia and sepiapterin reductase deficiency. Mol. Genet. Metab., 74, 172-185.
13. Nygaard, T.G., Takahashi, H., Heiman, G.A., Snow, B.J., Fahn, S. and Calne, D.B. (1992) Long-term treatment response and fluorodopa positron emission tomographic scanning of parkinsonism in a family with dopa-responsive dystonia. Ann. Neurol., 32, 603-608.
14. Lovenberg, W.., Levine, R.A., Robinson, D.S., Ebert, M., Williams, A.C. and Calne, D.B. (1979) Hydroxylase cofactor activity in cerebrospinal fluid of normal subjects and patients with Parkinson's disease. Science, 204, 624-626.
15. Schapira, A.H., Cooper, J.M., Dexter, D., Clark, J.B., Jenner, P. and Marsden, C.D. (1990) Mitochondrial complex I deficiency in Parkinson's disease. J. Neurochem., 54, 823-827.
16. Vettraino, J., Buck, S. and Arking, R. (2001) Direct selection for paraquat resistance in Drosophila results in a different extended longevity phenotype. J. Gerontol. A Biol. Sci. Med. Sci., 56, 13415-425.
17. Werner, T., Liu, G., Kang, D., Ekengren, S., Steiner, H. and Hultmark, D. (2000) A family of peptidoglycan recognition proteins in the fruit fly Drosophila melanogaster. Proc. Natl Acad. Sci. USA, 97, 13772-13777.
18. Wittmann, C.W., Wszolek, M.F., Shulman, J.M., Salvaterra, P.M., Lewis, J., Hutton, M. and Feany, M.B. (2001) Tauopathy in Drosophila: neurodegeneration without neurofibrillary tangles. Science, 293, 711-714.
19. Lee, V.M., Goedert, M. and Trojanowski, J.Q. (2001) Neurodegenerative tauopathies. A. Rev. Neurosci., 24, 1121-1159.
20. Kanzok, S.M., Fechner, A., Bauer, H., Ulschmid, J.K., Muller, H.M., Botella-Munoz, J., Schneuwly, S., Schirmer, R. and Becker, K. (2001) Substitution of the thioredoxin system for glutathione reductase in Drosophila melanogaster. Science, 291, 643-646.
21. Kins, S., Crameri, A., Evans, D.R., Hemmings, B.A., Nitsch, R.M. and Gotz, J. (2001) Reduced protein phosphatase 2A activity induces hyperphosphorylation and altered compartmentalization of tau in transgenic mice. J. Biol. Chem., 276, 38193-38200.
22. Lim, F., Hernandez, F., Lucas, J.J., Gomez-Ramos, P., Moran, M.A. and Avila, J. (2001) FTDP-17 mutations in tau transgenic mice provoke lysosomal abnormalities and Tau filaments in forebrain. Mol. Cell. Neurosci., 18, 702-714.
23. Cataldo, A.M., Barnett, J.L., Berman, S.A., Li, J., Quarless, S., Bursztajn, S., Lippa, C. and Nixon, R.A. (1995) Gene expression and cellular content of cathepsin D in Alzheimer's disease brain: evidence for early up-regulation of the endosomal-lysosomal system. Neuron, 14, 671-680.
24. Cataldo, A.M., Barnett, J.L., Pieroni, C. and Nixon, R.A. (1997) Increased neuronal endocytosis and protease delivery to early endosomes in sporadic Alzheimer's disease: neuropathologic evidence for a mechanism of increased beta-amyloidogenesis. J. Neurosci., 17, 6142-6151.
25. Liscovitch, M., Czarny, M., Fiucci, G. and Tang, X. (2000) Phospholipase D: molecular and cell biology of a novel gene family. Biochem. J., 345 (Pt 3), 401-415.
26. Kudo, I., Matsuzawa, A., Imai, K., Murakami, M. and Inoue, K. (1996) Function of type II phospholipase A2 in dopamine secretion by rat neuronal PC12 cells. J. Lipid. Mediat. Cell. Signal, 14, 25-31.
27. 2+ ionophore A23187-induced release of histamine from rat basophilic leukemia cells. Arch. Biochem. Biophys., 212, 572-580.
28. 2+-dependent phospholipase A2. Science, 216, 305-307.
29. Moskowitz, N., Schook, W. and Puszkin, S. (1984) Regulation of endogenous calcium-dependent synaptic membrane phospholipase A2. Brain Res., 290, 273-279.
30. Bradford, P.G., Marinetti, G.V. and Abood, L.G. (1983) Stimulation of phospholipase A2 and secretion of catecholamines from brain synaptosomes by potassium and A23187. J. Neurochem., 41, 1684-1693.
31. Karli, U.O., Schafer, T. and Burger, M.M. (1990) Fusion of neurotransmitter vesicles with target membrane is calcium independent in a cell-free system. Proc. Natl Acad. Sci. USA, 87, 5912-5915.
32. Wang, J.P. and Teng, C.M. (1990) Comparison of the enzymatic and edema-producing activities of two venom phospholipase A2 enzymes. Eur. J. Pharmacol., 190, 347-354.
33. Fujino, T., Kang, M.J., Suzuki, H., Iijima, H. and Yamamoto, T. (1996) Molecular characterization and expression of rat acyl-CoA synthetase 3. J. Biol. Chem., 271, 16748-16752.
34. Kutty, R.K., Kutty, G., Kambadur, R., Duncan, T., Koonin, E.V., Rodriguez, I.R., Odenwald, W.F. and Wiggert, B. (1996) Molecular characterization and developmental expression of a retinoid- and fatty acid-binding glycoprotein from Drosophila. A putative lipophorin. J. Biol. Chem., 271, 20641-20649.
35. Gai, W.P., Yuan, H.X., Li, X.Q., Power, J.T., Blumbergs, P.C. and Jensen, P.H. (2000) In situ and in vitro study of colocalization and segregation of alpha-synuclein ubiquitin, and lipids in Lewy bodies. Exp. Neurol., 166, 324-333.
36. Nishimura, M., Tomimoto, H., Suenaga, T., Nakamura, S., Namba, Y., Ikeda, K., Akiguchi, I. and Kimura, J. (1994) Synaptophysin and chromogranin A immunoreactivities of Lewy bodies in Parkinson's disease brains. Brain Res., 634, 339-344.
37. Sharon, R., Bar-Joseph, I., Frosch, M.P., Walsh, D.M., Hamilton, J.A. and Selkoe, D.J. (2003) The formation of highly soluble oligomers of alpha-synuclein is regulated by fatty acids and enhanced in Parkinson's disease. Neuron, 37, 583-595.
38. Lee, H.J., Shin, S.Y., Choi, C., Lee, Y.H. and Lee, S.J. (2002) Formation and removal of alpha-synuclein aggregates in cells exposed to mitochondrial inhibitors. J. Biol. Chem., 277, 5411-5417.
39. Volles, M.J., Lee, S.J., Rochet, J.C., Shtilerman, M.D., Ding, T.T., Kessler, J.C. and Lansbury; P.T., Jr (2001) Vesicle permeabilization by protofibrillar alpha-synuclein: implications for the pathogenesis and treatment of Parkinson's disease. Biochemistry, 40, 7812-7819.
40. Ginsberg, S.D., Hemby, S.E., Lee, V.M., Eberwine, J.H. and Trojanowski, J.Q. (2000) Expression profile of transcripts in Alzheimer's disease tangle-bearing CA1 neurons. Ann. Neurol., 48, 77-87.
41. Loring, J.F., Wen, X., Lee, J.M., Seilhamer, J. and Somogyi, R. (2001) A gene expression profile of Alzheimer's disease. DNA Cell Biol., 20, 683-695.
42. Lockhart, D.J., Dong, H., Byrne, M.C., Follettie, M.T., Gallo, M.V., Chee, M.S., Mittmann, M., Wang, C., Kobayashi, M., Horton, H. et al. (1996) Expression monitoring by hybridization to high-density oligonucleotide arrays. Nat. Biotechnol., 14, 1675-1680.